Bioengineering is revolutionizing cancer research. This area of science integrates engineering and physical sciences with oncology to change how we understand and treat this complex disease.

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

James Allison, (from left) regental professor and chair of immunology and director of the James P. Allison Institute at The University of Texas MD Anderson Cancer Center; Jeffrey Molldrem, chair of ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

The University of MD Anderson Cancer Center and Rice University, both based in Houston, have launched a Cancer Bioengineering Collaborative, a hub that aims to advance cancer research and accelerate ...

Led by Rice's Gang Bao and MD Anderson's Dr. Jeffrey Molldrem, the initiative aims to foster collaboration between the two institutions on fundamental and translational cancer research, to develop new ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Rice University and the MD ...

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers ...

Findings from a study co-led by UTSW reveal a possible mechanism behind a malignancy that has risen rapidly over the past few ...

EPFL researchers have demonstrated the first pill-sized bioprinter that can be swallowed and guided within the gastrointestinal tract, where it directly deposits bio-ink over damaged tissues to ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

TAMPA, Fla — Bioengineering is revolutionizing cancer research, and Moffitt Cancer Center is at the forefront of this transformative movement. Moffitt is the first National Cancer Institute-designated ...